Alopecia areata increases the risk of stroke: A 3-year follow-up study

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kang, Jiunn Horng ^a,b   Lin, Herng Ching ^a   Kao, Senyeong ^c   Tsai, Ming Chieh ^a,d   Chung, Shiu Dong ^a,e,f  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; COMPLICATION; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STROKE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84933575007     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11718     Document Type: Article

References (20)

1. Hordinsky, M. K. Overview of alopecia areata. J. Investig. Dermatol. Symp. Proc. 16, S13-15 (2013).
2. Ito, T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin. Dev. Immunol. 348546 (2013) doi: 10.1155/2013/348546.
3. Alkhalifah, A. Alopecia areata update. Dermatol. Clin. 31, 93-108 (2013).
4. Hon, K. L. & Leung, A. K. Alopecia areata. Recent. Pat. Inflamm. Allergy Drug Discov. 5, 98-107 (2011).
5. Alkhalifah, A. et al. Alopecia areata update: part II. Treatment. J. Am. Acad. Dermatol. 62, 191-202 (2010).
6. Garcia-Hernandez, M. J. et al. Alopecia areata, stress and psychiatric disorders: a review. J. Dermatol. 26, 625-632 (1999).
7. Gothe, F. et al. Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment. Panminerva Med. 54, 161-170 (2012).
8. Charo, I. F. & Taub, R. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat. Rev. Drug Discov. 10, 365-376 (2011).
9. Kitas, G. D. & Gabriel, S. E. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann. Rheum. Dis. 70, 8-14 (2011).
10. Grau, A. J., Urbanek, C. & Palm, F. Common infections and the risk of stroke. Nat, Rev, Neurol. 6, 681-694 (2010).
11. Behrouz, R. The risk of ischemic stroke in major rheumatic disorders. J. Neuroimmunol. 277, 1-5 (2014).
12. Huang, K. P. et al. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 149, 789-794 (2013).
13. Wollenweber, F. A. et al. Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke. Stroke 44, 1446-1448 (2013).
14. Karch, A. & Thomas, S. L. Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study. Neurology 82, 1643-1652 (2014).
15. Karakurum, Goksel. B. et al. Subclinical hypothyroidism, hyperhomocysteinemia and dyslipidemia: investigating links with ischemic stroke in Turkish patients. Neurol. Res. 29, 871-876 (2007).
16. Austin, R. C. et al. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 11, S56-64 (2004).
17. Albert, M. A. & Ridker, P. M. The role of C-reactive protein in cardiovascular disease risk. Curr. Cardiol. Rep. 1, 99-104 (1999).
18. Yousefi, M. et al. Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata. Indian J. Dermatol. 59, 630 (2014).
19. Bakry, O. A. et al. Oxidative stress in alopecia areata: a case-control study. Am J. Clin. Dermatol. 15, 57-64 (2014).
20. Dong, J. Y. et al. Depression and risk of stroke: a meta-analysis of prospective studies. Stroke 43, 32-37 (2012).